Abstract:55 Pancreatic transplantation is an important therapeutic alternative for type I diabetic patients with renal failure. Since systemic immunosuppression is required to prevent acute rejection and maintain long-term graft function, the enthusiasm for pancreas transplantation to restore normoglycemia and prevent the complications in non-uremic diabetic patients is muted. Inhibition of the CD28/B7 pathway during T cell activation by CTLA4Ig produces a state of T cell anergy, resulting in prolonged graft survival and donor-specific tolerance. We hypothesized that local production of CTLA4Ig from the pancreas graft, achieved by adenoviral-mediated transfer of the CTLA4Ig gene to the graft ex vivo, may inhibit the immune responses against the pancreas and promote long-term graft survival. Methods: Pancreaticoduodenal grafts from Lewis donors were infected by AdlacZ or AdCTLA4Ig via arterial perfusion of 2.5×1010 virus, followed by 1.5-hour ex vivo incubation at 4°C. Grafts were washed with saline and transplanted into STZ-diabetic recipients (Lewis or W/F). Syngeneic AdlacZ-infected grafts were harvested at various time points after transplantation and LacZ expression was examined by X-gal staining. All animals with graft rejection were sacrificed at the time of rejection, and graft morphology examined histologically. To determine the local vs. the systemic effect of the locally delivered CTLA4Ig, co-transplantation of the transfected pancreas with non-transfected heart allografts were performed in two allogeneic strain combinations. Results: X-gal staining of pancreas isografts demonstrated lacZ gene expression in the endocrine and exocrine cells of the donor grafts beginning 1 day post-transplantation, reaching peak levels by day 3. LacZ expression was also observed in the recipient liver, however, by day 7 lacZ expression diminished in the liver, and virtually disappeared by day 14, though high levels of LacZ in the pancreas grafts were detected. AdCTLA4Ig toxicity was evaluated by syngeneic transplantation of virus-infected pancreases (n=4) and a survival time of greater than 100 days was achieved. Transplantation of control (non-treated, n=6) or AdlacZ-infected Lewis rat pancreases (n=4) into W/F recipients gave a mean survival time of 17 and 17.5 days, respectively. However, transplantation of AdCTLA4Ig-infected pancreas grafts (n=6) resulted in permanent survival of the graft (> 100 days). Subsequent transplantation of donor strain hearts (n=3) did not induce rejection, and long-term heart allograft survival was observed. Transplantation of third party (ACI) heart allografts (n=3) were rejected, though the survival time of the grafts was prolonged to a small degree vs. control (MST 22d vs. 7d, p<0.01). In the co-transplantation model, the non-transfected hearts (H) were rejected while the transfected pancreases (Pd) were accepted, confirming the effect of locally delivered CTLA4Ig. TableTableConclusion: This study demonstrates that arterial perfusion of the pancreas with adenovirus can lead to successful viral infection and gene transfer. Local expression of the CTLA4Ig gene can produce long-term graft survival and donor-specific tolerance in the rat pancreas transplant model. The immunosuppressive effect of CTLA4Ig protein appears limited to the transfected tissue rather than a systemic phenomenon.

Adenoviral Transfection of Isolated Pancreatic Islets: A Study of Programmed Cell Death (Apoptosis) and Islet Function

Increased DNA fragmentation in isolated rat islets following 24 hour co-culture with cytokine transgene-bearing adenovirus is dose dependent, but does not reduce glucose-stimulated insulin secretion.

Adenovirus Transduction Induces Expression of Multiple Chemokines and Chemokine Receptors in Murine Β Cells and Pancreatic Islets

Protection of Rat Islet Viability Following Heme Oxygenase-1 Gene Transfection Via Adenoviral Vector in Vitro

Efficient, Glucose Responsive, and Cell-Specific Transgene Expression in Pancreatic Islets.

Transduction of Heme Oxygenase-1 Gene to Human Islet Cells Via Adenovirus Vector Enhances Anti- Apoptosis Function and Insulin Release

Transduction of pancreatic islets with pseudotyped adeno-associated virus: effect of viral capsid and genome conversion.

Protection of Human Islets from Induction of Apoptosis and Improved Islet Function with HO-1 Gene Transduction

Transient Embolization with Microspheres of Polyhydroxyalkanoate Renders Efficient Adenoviral Transduction of Pancreatic Capillaryin Vivo

Insulin gene transfer enhances the function of human islet grafts

Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector.

Highly efficient adenoviral transduction of pancreatic islets using a microfluidic device

Adenovirus vectors differentially modulate proliferation of pituitary lactotrophs in primary culture in a mitogen and infection time-dependent manner

Adiponectin Gene Therapy Prevents Islet Loss after Transplantation

LOCAL EXPRESSION OF RECOMBINANT CTLA4IG GENE IN THE PANCREAS INDUCES PERMANENT PANCREAS GRAFT SURVIVAL AND DONOR-SPECIFIC TOLERANCE:

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

QS313. Multiple Treatment Cycles of Liposome Encapsulation of Adenoviral RIP TK Gene Therapy Effectively Ablate Human Pancreatic Cancer Cells in SCID Mice

The Effect of FasL Gene Transfer to Islet Cells on Pancreatic Islet Allografts

Adenovirus‐mediated Interferon‐γ Gene Therapy Induced Human Pancreatic Carcinoma Capan‐2 Cell Apoptosis in Vitro and in Vivo

Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium

Induction of Immunotolerance in Mouse Pancreatic Islet Transplantation Through PD-1/PD-L1 Costimulatory Pathway